Comments
Unichem Laboratories on Monday informed the exchanges that its active pharmaceutical ingredient manufacturing units at Pithampur and Roha have received Establishment Inspection Reports from the US Food and Drug Administration. This indicates closure of inspections at both the facilities, Unichem said in the filing. The inspection at Pithampur was conducted from July 23 to July 27, and for Roha unit between July 30 and August 3. Shares of Unichem Laboratories on Monday gained 2.80 per cent at ₹212.90 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.